| # | Title | Journal | Year | Citations |
|---|
| 1 | Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the US Population, 2012 | JAMA Dermatology | 2015 | 1,290 |
| 2 | Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab | JAMA Dermatology | 2016 | 539 |
| 3 | Global Skin Disease Morbidity and Mortality | JAMA Dermatology | 2017 | 457 |
| 4 | Factors Predictive of Recurrence and Death From Cutaneous Squamous Cell Carcinoma | JAMA Dermatology | 2013 | 448 |
| 5 | Psoriasis Severity and the Prevalence of Major Medical Comorbidity | JAMA Dermatology | 2013 | 402 |
| 6 | Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression | JAMA Dermatology | 2015 | 385 |
| 7 | Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death | JAMA Dermatology | 2016 | 374 |
| 8 | Diagnostic Inaccuracy of Smartphone Applications for Melanoma Detection | JAMA Dermatology | 2013 | 337 |
| 9 | Undertreatment, Treatment Trends, and Treatment Dissatisfaction Among Patients With Psoriasis and Psoriatic Arthritis in the United States | JAMA Dermatology | 2013 | 327 |
| 10 | Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis | JAMA Dermatology | 2015 | 308 |
| 11 | Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis | JAMA Dermatology | 2020 | 297 |
| 12 | Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum | JAMA Dermatology | 2018 | 292 |
| 13 | Long-term Management of Adult Vulvar Lichen Sclerosus | JAMA Dermatology | 2015 | 287 |
| 14 | Machine Learning and Health Care Disparities in Dermatology | JAMA Dermatology | 2018 | 281 |
| 15 | Evaluation of AJCC Tumor Staging for Cutaneous Squamous Cell Carcinoma and a Proposed Alternative Tumor Staging System | JAMA Dermatology | 2013 | 277 |
| 16 | Psoriasis and the Risk of Diabetes Mellitus | JAMA Dermatology | 2013 | 262 |
| 17 | Sex- and Age-Adjusted Population Analysis of Prevalence Estimates for Hidradenitis Suppurativa in the United States | JAMA Dermatology | 2017 | 258 |
| 18 | Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040 | JAMA Dermatology | 2022 | 254 |
| 19 | Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis | JAMA Dermatology | 2020 | 247 |
| 20 | Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis | JAMA Dermatology | 2020 | 241 |
| 21 | International Prevalence of Indoor Tanning | JAMA Dermatology | 2014 | 240 |
| 22 | Persistence of Mild to Moderate Atopic Dermatitis | JAMA Dermatology | 2014 | 238 |
| 23 | Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis | JAMA Dermatology | 2021 | 236 |
| 24 | Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis | JAMA Dermatology | 2017 | 235 |
| 25 | Laser Treatment of Traumatic Scars With an Emphasis on Ablative Fractional Laser Resurfacing | JAMA Dermatology | 2014 | 225 |
| 26 | Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States | JAMA Dermatology | 2017 | 223 |
| 27 | The Follicular Skin Microbiome in Patients With Hidradenitis Suppurativa and Healthy Controls | JAMA Dermatology | 2017 | 217 |
| 28 | Tofacitinib Citrate for the Treatment of Vitiligo | JAMA Dermatology | 2015 | 215 |
| 29 | Relationship Between theHLA-B*1502Allele and Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis | JAMA Dermatology | 2013 | 213 |
| 30 | Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa | JAMA Dermatology | 2016 | 205 |
| 31 | Association Between Surgical Skin Markings in Dermoscopic Images and Diagnostic Performance of a Deep Learning Convolutional Neural Network for Melanoma Recognition | JAMA Dermatology | 2019 | 201 |
| 32 | Incidence of Nonmelanoma Skin Cancer in Relation to Ambient UV Radiation in White Populations, 1978-2012 | JAMA Dermatology | 2014 | 199 |
| 33 | Expert-Level Diagnosis of Nonpigmented Skin Cancer by Combined Convolutional Neural Networks | JAMA Dermatology | 2019 | 199 |
| 34 | Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis | JAMA Dermatology | 2020 | 194 |
| 35 | Economic Burden of Psoriasis in the United States | JAMA Dermatology | 2015 | 189 |
| 36 | Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Immunotherapy | JAMA Dermatology | 2016 | 188 |
| 37 | Risk of Major Adverse Cardiovascular Events and All-Cause Mortality in Patients With Hidradenitis Suppurativa | JAMA Dermatology | 2016 | 186 |
| 38 | Effects of Low-Dose Recombinant Interleukin 2 to Promote T-Regulatory Cells in Alopecia Areata | JAMA Dermatology | 2014 | 185 |
| 39 | Pyogenic Arthritis, Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa (PAPASH): A New Autoinflammatory Syndrome Associated With a Novel Mutation of the PSTPIP1 Gene | JAMA Dermatology | 2013 | 183 |
| 40 | Epidemiology of Inherited Epidermolysis Bullosa Based on Incidence and Prevalence Estimates From the National Epidermolysis Bullosa Registry | JAMA Dermatology | 2016 | 176 |
| 41 | Effect of Weight Loss on the Severity of Psoriasis | JAMA Dermatology | 2013 | 175 |
| 42 | Teledermatology for the Diagnosis and Management of Skin Cancer | JAMA Dermatology | 2017 | 174 |
| 43 | Association of Psoriasis With Inflammatory Bowel Disease | JAMA Dermatology | 2018 | 174 |
| 44 | Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis | JAMA Dermatology | 2019 | 174 |
| 45 | Comparison of Biologics and Oral Treatments for Plaque Psoriasis | JAMA Dermatology | 2020 | 169 |
| 46 | Autoimmune, Atopic, and Mental Health Comorbid Conditions Associated With Alopecia Areata in the United States | JAMA Dermatology | 2013 | 168 |
| 47 | Changing Incidence Trends of Cutaneous T-Cell Lymphoma | JAMA Dermatology | 2013 | 166 |
| 48 | Psoriasis Prevalence in Adults in the United States | JAMA Dermatology | 2021 | 165 |
| 49 | Evaluation of Clinical Results, Histological Architecture, and Collagen Expression Following Treatment of Mature Burn Scars With a Fractional Carbon Dioxide Laser | JAMA Dermatology | 2013 | 163 |
| 50 | Outcomes of Primary Cutaneous Squamous Cell Carcinoma With Perineural Invasion | JAMA Dermatology | 2013 | 161 |
